drugset / Trial / NCT00435487

Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome

NCT00435487

Phase 4 Terminated 173 enrolled Pfizer
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare efficacy and safety of dalteparin compared to unfractionated heparin in patients of non ST elevation acute coronary syndromes who are planned to undergo coronary interventions (angioplasty or bypass surgery)

Timeline

Start
2007-06
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dalteparin sodium Other / unclassified 120 iu/kg Subcutaneous
Comparator Heparin Other / unclassified 12 iu/kg Intravenous